Jerusalem hospital shows off vaccine that destroys cancer in 2 shots. |
 Early human test results suggest a vaccine can train cancer patients' bodies to seek out and destroy tumour cells.The therapy, which targets a molecule found in 90 per cent of cancers, eventually could provide an injection that would allow patients' immune systems to fight off common cancers including breast and prostate cancer. The first results of trials in people, at the Hadassah Medical Centre in Jerusalem, suggest the vaccine can reduce levels of disease. The human work is so preliminary it has yet to be published in a scientific journal. The scientists behind the vaccine hope to conduct more extensive trials to prove it can be effective against a range of cancers. They believe it could be used to fight small tumours if they are detected early or to help prevent the return and spread of disease in patients who have undergone conventional treatment. In the safety trial at Hadassah, 10 patients with multiple myeloma, a blood cancer, received the vaccine. Seven have finished the treatment and the developer, drug company Vaxil Biotherapeutics, reported all had greater immunity against cancer cells compared with before they were given the vaccine. Vaxil added that three patients were free of detectable cancer following the treatment. Cancer cells usually evade a patient's immune system because they are not recognized as a threat. While the immune system usually attacks foreign cells such as bacteria, tumours are formed of the patient's own cells that have malfunctioned. Scientists have discovered that a molecule called MUC1, which is found on the surface of cancer cells, can be used to help the immune sys-tem detect tumours. The new vaccine, ImMucin, developed by Vaxil and researchers at Tel Aviv University, uses a section of the molecule to prime the immune system so it can identify and thus destroy cancer cells. Vaxil suggested that if large-scale trials prove as successful, the vaccine could be available within six years. Initial research on the vaccine, in mice, was published in the journal Vaccine, and suggested the treatment induced "potent" immunity in mice and increased their survival from cancer. Cancer charities gave the vaccine a cautious welcome. Dr. Kat Arney, at Cancer Research UK, said: "These are very early results that are yet to be fully published, so there's a lot more work to be done to prove that this particular vaccine is safe and effective in cancer patients." |
I must like the Safe & effective clause, as opposed to what, Chemotherapy? Which is semi effective and Dangerous to the patient. My Daughter has been fighting Brain Cancer for 5 yrs now, Chemo about did her in,then the Radiation, brain surgery was some what effective, then she was used as a guinea pig by doctors who gave her all types of meds as they Guessed what to do next. Some caused the side effects like Seizures while they tried to stop the seizures, lots of guess work. Today she is 19, the cancer tumor has not grown-what they could not remove. However she has lost one eye, If in America the FDA would approve known cures, known and effective solutions it would be helpful, however they like their hundreds of millions they make off each new drug they approve or disapprove in the years long process, like the FDA is more in it for the $$$$ Profit than helping Sick people. I hope this works, many suffer, many need a cure. The side effects of current treatments are not acceptable in the long run, as they are terrible, my daughter is currently unemployable, unable to drive, working on finishing her GED via On Line courses as sounds/lights/etc in the Public will put her into a seizure. Effects of her treatments. Hopefully one day we will find ways to help her. But a Cure is most needed for all.
ReplyDelete